CLSI I/LA28-A2 (R2018)
Quality Assurance for Design Control and Implementation of Immunohistochemistry Assays; Approved Guideline-Second Edition, ILA28A2E
standard by Clinical and Laboratory Standards Institute, 01/01/2011
CLSI M57-Ed1
Principles and Procedures for the Development of Epidemiological Cutoff Values for Antifungal Susceptibility Testing
standard by Clinical and Laboratory Standards Institute, 04/25/2016
CLSI VET02-A3
Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters for Veterinary Antimicrobial Agents; Approved Guideline – Third Edition, VET02A3E
standard by Clinical and Laboratory Standards Institute, 02/25/2008
CLSI I/LA21-A2
Clinical Evaluation of Immunoassays; Approved Guideline–Second Edition, ILA21A2E
standard by Clinical and Laboratory Standards Institute, 01/01/2008
CLSI GP41-A6
Procedures for the Collection of Diagnostic Blood Specimens by Venipuncture; Approved Standard-Sixth Edition, GP41A6E
standard by Clinical and Laboratory Standards Institute, 11/01/2007
CLSI EP05-A3 (R2019)
Evaluation of Precision of Quantitative Measurement Methods; Approved Guideline, EP05A3E
standard by Clinical and Laboratory Standards Institute, 09/01/2014
CLSI C59-A
Apolipoprotein Immunoassays: Development and Recommended Performance Characteristics; Approved Guideline, C59AE
standard by Clinical and Laboratory Standards Institute, 09/19/1997
CLSI NBS07-Ed1
Newborn Blood Spot Screening for Pompe Disease by Lysosomal Acid alpha-Glucosidase Activity Assays, 1st Edition, NBS07Ed1E
standard by Clinical and Laboratory Standards Institute, 03/01/2017
CLSI M22-A3 (R2018)
Quality Control for Commercially Prepared Microbiological Culture Media; Approved Standard, M22A3E
standard by Clinical and Laboratory Standards Institute, 06/20/2004
CLSI QMS21
Purchasing and Inventory Management, 1st Edition, QMS21Ed1E
standard by Clinical and Laboratory Standards Institute, 11/01/2016